Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Frezzetti
Observed names:
D Frezzetti,
D. Frezzetti,
FREZZETTI, DANIELA,
Frezzetti Daniela,
Frezzetti, Daniela
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
Fudan University Shanghai Cancer Center,
Biogem,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Naples Federico II
ORCID:
0000-0002-7500-5506
Observed ORCID:
0000-0002-7500-5506
OpenAlex ID:
A5049567032
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
2007
·
Pablo Landgraf
, Mirabela Rusu
, et al.
·
Cell
·
4,027
PDF
VEGF as a potential target in lung cancer
2017
·
Daniela Frezzetti
, Marianna Gallo
, et al.
·
Expert Opinion on Therapeutic Targets
·
260
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
2010
·
D Frezzetti
, M De Menna
, et al.
·
Oncogene
·
145
Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
2020
·
Riziero Esposito Abate
, Daniela Frezzetti
, et al.
·
Cancers
·
71
PDF
The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function
2011
·
Daniela Frezzetti
, Carla Reale
, et al.
·
PLoS ONE
·
65
PDF
Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells
2015
·
Daniela Frezzetti
, Marianna Gallo
, et al.
·
Journal of Cellular Physiology
·
59
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents
2019
·
Anna Maria Rachiglio
, Matilde Lambiase
, et al.
·
Cancers
·
46
PDF
FGFR-targeted therapeutics for the treatment of breast cancer
2017
·
Antonella De Luca
, Daniela Frezzetti
, et al.
·
Expert Opinion on Investigational Drugs
·
36
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells
2018
·
Marianna Gallo
, Daniela Frezzetti
, et al.
·
Oncotarget
·
30
PDF
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer
2018
·
Antonella De Luca
, Monica R. Maiello
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
29
Selective Dicer Suppression in the Kidney Alters GSK3β/β-Catenin Pathways Promoting a Glomerulocystic Disease
2015
·
Anna Iervolino
, Francesco Trepiccione
, et al.
·
PLoS ONE
·
25
PDF
The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
2019
·
Marianna Gallo
, Antonella De Luca
, et al.
·
Expert Review of Molecular Diagnostics
·
19
RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
2014
·
Antonella De Luca
, Cristin Roma
, et al.
·
Oncotarget
·
19
PDF
The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
2022
·
Marianna Gallo
, Marianeve Carotenuto
, et al.
·
Cancers
·
16
PDF
Vandetanib as a potential treatment for breast cancer
2014
·
Antonella De Luca
, Amelia D’Alessio
, et al.
·
Expert Opinion on Investigational Drugs
·
15
Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients
2019
·
Daniela Frezzetti
, Antonella De Luca
, et al.
·
Journal of Thoracic Disease
·
13
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
2024
·
Riziero Esposito Abate
, Raffaella Pasquale
, et al.
·
Journal for ImmunoTherapy of Cancer
·
12
PDF
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
2022
·
Cristin Roma
, Alessandra Sacco
, et al.
·
Diagnostics
·
9
PDF
The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells
2024
·
Daniela Frezzetti
, Vincenza Caridi
, et al.
·
International Journal of Molecular Sciences
·
7
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood
2025
·
Caterina De Rosa
, Luisa Amato
, et al.
·
The Journal of Liquid Biopsy
·
6
PDF
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
2026
·
Angela Damato
, Riziero Esposito Abate
, et al.
·
Nature Communications
·
5
PDF
Abstract 4343: Effects of the co-expression of RANTES and IL-6 on the transformed phenotype of breast cancer cells
2017
·
Marianna Gallo
, Daniela Frezzetti
, et al.
·
Cancer Research
·
3
REDAC: RNA-seq expression data analysis chatbot
2025
·
Giovanni Maria De Filippis
, Pranoy Sahu
, et al.
·
Bioinformatics Advances
·
2
PDF
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer Cells
2026
·
Brigitta Ignoto
, Ilaria Assunta Parisi
, et al.
·
Cells
MiR-23c regulates the resistance to gefitinib in EGFR mutant Non-Small Cell Lung Cancer cells
2026
·
Ignoto, Brigitta
, De Luca, Antonella
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
39
Citation count:
4,919
H-index:
15
I10-index:
17
Year
Topic
Type